These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 32576461)
1. Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context. Grieco L; Panovska-Griffiths J; van Leeuwen E; Grove P; Utley M Vaccine; 2020 Jul; 38(33):5163-5170. PubMed ID: 32576461 [TBL] [Abstract][Full Text] [Related]
2. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios. Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Oshansky CM; Zhou J; Gao Y; Schweinle JE; Biscardi K; DeBeauchamp J; Pavetto C; Wollish A; ; Webby RJ; Cioce V; Donis RO; Bright RA Vaccine; 2019 Jan; 37(3):435-443. PubMed ID: 30553570 [TBL] [Abstract][Full Text] [Related]
4. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. Nuño M; Chowell G; Gumel AB J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132 [TBL] [Abstract][Full Text] [Related]
5. A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza. Crowe S; Utley M; Walker G; Grove P; Pagel C Vaccine; 2011 Jul; 29(31):5065-77. PubMed ID: 21539879 [TBL] [Abstract][Full Text] [Related]
6. PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness. Ghiga I; Richardson S; Álvarez AMR; Kato M; Naidoo D; Otsu S; Nguyen PT; Nguyen PN; Nguyen T Vaccine; 2021 Jan; 39(2):364-371. PubMed ID: 33293160 [TBL] [Abstract][Full Text] [Related]
7. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Medema JK; Zoellner YF; Ryan J; Palache AM Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482 [TBL] [Abstract][Full Text] [Related]
8. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response. Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633 [TBL] [Abstract][Full Text] [Related]
10. Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States. Biggerstaff M; Reed C; Swerdlow DL; Gambhir M; Graitcer S; Finelli L; Borse RH; Rasmussen SA; Meltzer MI; Bridges CB Clin Infect Dis; 2015 May; 60 Suppl 1(Suppl 1):S20-9. PubMed ID: 25878298 [TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States. Dauelsberg LR; Maskery B; Joo H; Germann TC; Del Valle SY; Uzicanin A BMC Public Health; 2024 Jan; 24(1):200. PubMed ID: 38233845 [TBL] [Abstract][Full Text] [Related]
12. Vaccination against influenza: role and limitations in pandemic intervention plans. Rebmann T; Zelicoff A Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487 [TBL] [Abstract][Full Text] [Related]
14. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old. Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001 [TBL] [Abstract][Full Text] [Related]
15. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness. Ruscio B; Bolster A; Bresee J; Vaccine; 2020 Apr; 38(16):3179-3183. PubMed ID: 32171576 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions. Dorratoltaj N; Marathe A; Lewis BL; Swarup S; Eubank SG; Abbas KM PLoS Comput Biol; 2017 Jun; 13(6):e1005521. PubMed ID: 28570660 [TBL] [Abstract][Full Text] [Related]
17. Pandemic influenza preparedness in the WHO African region: are we ready yet? Sambala EZ; Kanyenda T; Iwu CJ; Iwu CD; Jaca A; Wiysonge CS BMC Infect Dis; 2018 Nov; 18(1):567. PubMed ID: 30428846 [TBL] [Abstract][Full Text] [Related]
19. [Pandemic preparedness planning. What did we learn from the influenza pandemic (H1N1) 2009?]. Schaade L; Reuss A; Haas W; Krause G Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Dec; 53(12):1277-82. PubMed ID: 21161478 [TBL] [Abstract][Full Text] [Related]
20. Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention. Basili M; Ferrini S; Montomoli E Eur J Public Health; 2013 Aug; 23(4):669-73. PubMed ID: 23531523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]